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Abstract The absence of coronary calcification is associ-
ated with an excellent prognosis. However, a calcium score
of zero does not exclude the presence of coronary artery
disease (CAD) or the possibility of future cardiovascular
events. Our aim was to study the prevalence and predictors of
coronary artery disease in patients with a calcium score of
zero. Prospective registry consisted of 3,012 consecutive
patients that underwent cardiac CT (dual source CT). Stable
patients referred for evaluation of possible CAD that had a
calcium score of zero (n = 864) were selected for this
analysis. The variables that were statistically significant
were included in a multivariable logistic regression model.
From 864 patients with a calcium score of zero, 107 (12.4 %)
had coronary plaques on the contrast CT (10.8 %, n = 93
with nonobstructive CAD and 1.6 %, n = 14 with obstruc-
tive CAD). By logistic regression analysis, the independent
predictors of CAD in this population were age [55 years
[odds ratio (OR) 1.63 (1.05–2.52)], hypertension [OR 1.64
(1.05–2.56)] and dyslipidemia [OR 1.54 (1.00–2.36)]. In the
presence of these 3 variables, the probability of having cor-
onary plaques was 21 %. The absence of coronary artery
calcification does not exclude the presence of coronary artery
disease, but the prevalence of obstructive disease is very low.
In this population, the independent predictors of CAD in the
setting of a calcium score of zero were hypertension, dysli-
pidemia, and age above 55 years. In the presence of these 3
predictors, the probability of having CAD was almost 2 times
higher than in the general population.
Keywords Zero calcium score  Coronary artery
disease  Noncalcified plaque
Introduction
Coronary artery disease (CAD) is a major cause of death in
developed countries and it is expected to remain the most
important disease in the upcoming years [1].
Quantification of coronary artery calcium [calcium scor-
ing (CaSc)] can provide a measure of the atherosclerotic
plaque burden, since coronary arterial calcification occurs
almost exclusively in atherosclerotic plaques [2, 3]. Also, it
has been demonstrated in many large clinical trials, that
CaSc is a strong predictor of cardiovascular events [4–7].
On the other hand, the absence of calcium in the coronary
arteries, although it does not rule out atherosclerotic disease,
is consistent with an excellent long-term prognosis [8] and
has a high sensitivity and negative predictive value for
excluding obstructive CAD. This fact prompted some recent
guidelines to suggest that a calcium score of zero might
exclude the need for coronary angiography in symptomatic
patients [9]. Nevertheless, in previous studies, a high varia-
tion was reported in the incidence of obstructive CAD in
patients with a CaSc of zero, ranging from 2 to 32 % [10–15].
For instance, in the recent CONFIRM registry, it was shown
that in patients with a CaSc of zero, obstructive CAD is
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possible and is associated with increased cardiovascular
events [16]. The aim of this study was to assess the preva-
lence and predictors of coronary artery disease in a popula-
tion of stable patients referred for evaluation of possible
CAD who had a calcium score of zero.
Methods
Study design and patient population
Single center prospective registry including 3,012 consecu-
tive patients undergoing dual source coronary CT angiog-
raphy (CCTA) from February 2007 to March 2012. For this
analysis, 864 stable patients (with symptoms and/or positive
or inconclusive stress tests) referred for evaluation of pos-
sible CAD that had a calcium score of zero were included.
Exclusion criteria included: (1) preoperative CAD
assessment prior to noncoronary valvular or aortic surgery
(n = 51); (2) evaluation of possible CAD in cardiomyopa-
thies (dilated cardiomyopathy or hypertrophic cardiomyop-
athy) (n = 162); (3) cardiac CT for atrial fibrillation ablation
(n = 330); (4) previous myocardial infarction and/or
revascularization procedures (n = 257); (5) suspected ACS
(n = 70); (6) other indications (n = 102). Patients with
atrial fibrillation or other significant arrhythmias during scan
acquisition or artifacts that significantly compromised image
quality were also excluded, as every patient with a CaSc[0
(Fig. 1).
The study was approved by the local ethics committee
and all patients gave a written informed consent.
A detailed medical history with a questionnaire investi-
gating risk factors was obtained from the patients to assess
for the presence of: (1) Diabetes mellitus (defined as a fasting
glucose level of C126 mg/dl or the need for insulin or oral
hypoglycemic agents) [17]; (2) Dyslipidemia (defined as a
total cholesterol level C200 mg/dl or treatment with lipid-
lowering drugs) [18]; (3) Hypertension (defined as blood
pressure C140/90 mmHg or the use of antihypertensive
medication) [19]; (4) Obesity (body mass index C30 kg/m2);
(5) positive family history of premature CAD (defined as the
presence of CAD in first-degree relatives younger than 55
(male) or 65 (female) years of age) [20]; (6) smoking
(defined as previous (less\1 year) or current smoker).
Pre-test probability of CAD was determined using both
the modified Diamond and Forrester [21] and the Morise
score [22]. The cardiovascular risk was assessed with the
Heart Score [23]. In the modified Diamond–Forrester,
patients were classified into very low (\5 %), low (\10 %),
intermediate (10–90 %) and high probability ([90 %). For
the Morise score, patients were classified into low (scores
0–8), intermediate (scores 9–15) and high probability (scores
C16). For the Heart Score, the cut-off of C5 % (high-risk)
was used.
Fig. 1 Patient selection and
study design
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Scan protocol and image reconstruction
All scans were performed with the first generation of dual-
source scanner (Somatom Definition, Siemens Medical,
Germany), with the patient in dorsal decubitus and in deep
inspiration breath-hold.
The calcium score acquisition consisted of step and
shoot—prospective ECG triggering at 70 % of the R–R
interval if the heart rate was below 80 beats per min (bpm)
or at 40 % of the R–R interval if the heart rate was higher.
From the topogram, a cranio-caudal scan was obtained
from the carina to the plane just below the heart silhouette,
with 120 kV and 128 mAs/rot tube current, with CARE-
Dose 4D mAs modulation. The value of the calcium score
was obtained with the analysis of consecutive non-contrast
3 mm slices, with a reconstruction b35f Kernel and a small
(cardiac) FOV, with a dedicated software (CaSc–Siemens),
where every area at least with 3 mm2 within a coronary
vessel with a density above 130 HU (Hounsfield Units)
was selected.
For CCTA, sublingual nitroglycerin was administered to
all patients, except when contraindicated, and intravenous
metoprolol (5 mg, with a titration dose up to 20 mg) was
administered in patients with heart rate [70 bpm.
During the scan acquisition, a bolus of iodinated contrast
was injected at a 6 ml/s infusion rate, followed by a 50-ml
saline flush. The dose of contrast was calculated according to
the following formula: (acquisition time ? 6 s delay) 9
flow (6 ml/s). A ROI was defined in the ascending aorta for
the bolus trigger technique, set at 120 HU.
Dose reduction strategies—including electrocardio-
gram-gated tube current modulation, reduced tube voltage,
and prospective axial triggering—were used whenever
feasible.
Mean estimated radiation dose was 0.8 ± 0.5 mSv for
CaSc and 4.6 ± 3.8 mSv for CT scan. Mean contrast dose
was 96.2 ± 13.6 ml and heart rate was 67.8 ± 12.9 bpm.
Transaxial images were reconstructed with a temporal
resolution of 83 ms and slice thickness of 0.75 mm with
0.4 mm increments. Post-processing was carried out using
Circulation software, with multiplanar reconstructions,
maximum intensity projection and volume rendering
technique. All scans were analysed independently in the
same session by both a cardiologist and a radiologist with
level III equivalent experience by the Society of Cardio-
vascular Computed Tomography. In case of disagreement,
a joint reading was performed and a consensus decision
was reached.
In each coronary artery segment, coronary atheroscle-
rosis was defined as tissue structures [1 mm2 that existed
either within the coronary artery lumen or adjacent to the
coronary artery lumen that could be discriminated from
surrounding pericardial tissue, epicardial fat, or the vessel
lumen itself [24]. Coronary atherosclerotic lesions were
quantified for stenosis by visual estimation. Percent
obstruction of coronary artery lumen was based on a
comparison of the luminal diameter of the segment
exhibiting obstruction to the luminal diameter of the most
normal-appearing site immediately proximal to the plaque.
Obstructive CAD was defined by presence of at least one
plaque with C50 % stenosis.
Statistical analysis
Continuous variables with normal distribution were
expressed as mean ± standard deviation. Categorical vari-
ables were expressed as percentages and their frequencies
were compared with the Chi square test.
Binary logistic regression models were built to eluci-
date independent predictors of CAD without coronary
calcification.
The objective of this model was the assessment of
clinical variables that aid to predict the presence of CAD in
patients with a calcium score of zero. All the demographic,
risk factors and clinical variables present in Table 2 that
had a p \0.1 in univariate analysis were included in a
multivariate logistic regression model (Enter method).
Statistical analysis was performed with SPSS 17.0
software for Windows (SPSS Inc., Chicago, IL, USA).
Results
Baseline and procedural characteristics
In the final study population of 864 patients, most of the
patients were female (55 %) and mean age was
53.8 ± 11.0 years. The prevalence of traditional risk factors
was low, with only 9.0 % of patients with diabetes. This was
predominantly a low risk population with few high risk
patients (only 9.0 % with the Morise score and 3.1 % with
the modified Diamond–Forrester had a high CAD probabil-
ity). Likewise, most of the patients were not considered as
high cardiovascular risk, as assessed by the Heart Score (only
11.9 % had a Heart Score C5 %)—Table 1.
Coronary plaques were detected on CCTA in 107
patients (12.4 %): 10.8 % (n = 93) with nonobstructive
CAD and 1.6 % (n = 14) with obstructive CAD—Fig. 2.
Considering the degree of stenosis of the obstructive CAD
group, 64 % (n = 9) had a 50–70 % stenosis and 36 %
(n = 5) a [70 % stenosis. Considering the extent of dis-
ease, all these patients had obstructive CAD in only 1
vessel and 93 % had a single lesion. Regarding the distri-
bution, most of the obstructive CAD lesions were found in
proximal or mid segment locations (87 %), and the most
affected artery was the right coronary artery 50 % (n = 7).
Int J Cardiovasc Imaging (2013) 29:1839–1846 1841
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Left anterior descendent was affected in 5 patients, while
left main was affected in one patient and the circumflex
artery in other patient.
There were no significant differences in the prevalence
of CAD in patients referred for CCTA because of positive/
inconclusive stress tests (93/722 = 12.9 %) versus patients
referred without previous stress tests (14/142 = 9.9 %),
p = 0.403.
We further analyzed the distribution of CAD in the
different pretest probability subgroups. Using those defined
by Morise, the prevalence of CAD (any plaque) was 7.9,
14.3 and 20.5 % in low, intermediate and high pretest
probability patients, respectively. Regarding obstructive
CAD, a higher prevalence was also found in patients with
high pretest probability, but this increase was not statisti-
cally significant (Table 2).
Univariate analysis
Patients with CAD were older (prevalence of age C55 years
64 vs. 47 %, p = 0.001) than patients without CAD and had
a higher prevalence of dyslipidemia (65 vs. 51 %,
p = 0.010) and hypertension (67 vs. 51 %, p = 0.002).
The pre-test CAD probability assessed both by the
Morise score and the modified Diamond–Forrester was
higher in the CAD group and these patients had a 2–4 times
higher probability of being of a high CAD probability
group. Cardiovascular risk, estimated by the Heart Score,
was also significantly higher in patients with CAD.
Although there was a trend in this group towards a higher
prevalence of diabetes and male gender, these differences
were not statistically significant—Table 3.
Multivariate analysis
By multivariate analysis, the independent predictors of CAD
in patients with a calcium score of zero were age C55 (OR
1.631, 95 % CI 1.054–2.524, p = 0.028), hypertension (OR
Table 1 Demographic, clinical and CCTA characteristics of the
study population
All patients (n = 864)
Demographic
Age 53.8 ± 11.0
Male sex 389 (45.0)
Risk factors
Obesity (BMI C 30) 160 (18.5)
Diabetes 78 (9.0)
Hypertension 459 (53.1)
Dyslipidemia 454 (52.5)
Smoking 206 (23.8)
Family history of premature CAD 284 (32.9)
Chest pain
Asymptomatic 441 (51.0)
Noncardiac 194 (22.5)
Atypical 182 (21.1)
Typical 47 (5.4)
CAD probability—Morise
Score C16 78 (9.0)
Score 9–15 446 (51.6)
Score 0–8 340 (39.4)
CAD probability—modified Diamond Forrester
Very low 188 (21.8)
Low 391 (45.3)
Intermediate 257 (29.7)
High 27 (3.1)
CV risk
Heart Score C5 % 103 (11.9)
CCTA
Normal/no plaque 757 (87.6)
Non obstructive CAD 93 (10.8)
Obstructive CAD 14 (1.6)
Technical data
Heart rate (bpm) 67.8 ± 12.9
Contrast dose (ml) 96.2 ± 13.6
Radiation dose—CTA (mSv) 4.6 ± 3.8
Radiation dose—CaSc (mSv) 0.8 ± 0.5
Values are mean ± SD or n (%)
BMI body mass index, CAD coronary artery disease, CV cardiovas-
cular, CCTA coronary computed tomography angiography, bpm beats
per minute, mSv milisievert
87,6%
12,4%
10,8%
1,6%
Fig. 2 Distribution of CT angiographic findings
Table 2 Prevalence of CAD according to the pretest probability
(Morise)
Pretest probability Nonobstructive CAD Obstructive CAD
Low (n = 340) 27 (7.9 %) 6 (1.8 %)
Intermediate (n = 446) 64 (14.3 %) 6 (1.3 %)
High (n = 78) 16 (20.5 %) 2 (2.6 %)
p 0.002 0.708
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1.641, 95 % CI 1.051–2.560, p = 0.029) and dyslipidemia
(OR 1.538, 95 % CI 1.002–2.361, p = 0.049) (Fig. 3). In the
presence of these 3 variables (n = 176 patients, 20.4 % of
the population), the probability of having coronary plaques
was 21 % (vs. 12.4 % in the total studied population). We
also analyzed the prevalence of CAD according to the
presence of none, one, two or three of these risk factors. The
results are shown in Table 4.
Discussion
In this single center cohort of stable patients without
known CAD, referred for cardiac CT angiography, we
found a very low prevalence of obstructive CAD (1.6 %) in
the subset with a CaSc of zero. When considering the
degree of stenosis, only 0.6 % had a stenosis [70 %.
The prevalence and clinical significance of obstructive
CAD on coronary CT angiography among patients with a
calcium score of zero has been evaluated in several
cohorts, but with conflicting results, depending on the
population included. Data from Nieman et al. [14], the
CONFIRM registry [16], Rubinshtein et al. [13] and Akram
et al. [11], are in line with our results, with a low preva-
lence of obstructive CAD (2, 3.5, 7.2 and 8.2 %, respec-
tively). Our prevalence was even lower, and this might be
explained by a high prevalence of patients with a low
pretest probability of CAD.
In contrast, in the work of Harberl et al. [10] and
Gottlieb et al. [12], there was a high prevalence of CAD
(32 and 19.4 %, respectively), which can be related to the
fact that these studies included patients referred for con-
ventional angiography, including patients with possible
acute coronary syndromes.
In our population, the prevalence of CAD in patients
with positive/inconclusive stress tests (exercise electro-
cardiography in most cases) was not significantly different
from that of patients referred to CCTA without previous
tests, as in the study from Nieman et al. [14].
Calcium scoring enables a noninvasive quantification of
the total coronary atherosclerotic burden, although it
underestimates the burden of disease, by not measuring
noncalcified plaques [25]. Nevertheless, it has been shown
to outperform traditional risk stratification tools, such as
clinical risk factor assessment, ankle-brachial index, car-
otid intima-media thickness and high-sensitivity C-reactive
protein, as a predictor of cardiovascular events [4, 5].
Our data suggests that, although the absence of calcium
does not exclude the presence of CAD, it was associated
with a very low probability of obstructive lesions. This was
especially true in cases of low and intermediate pretest
CAD probability, as in the study from Werkhoven et al.
[15] in which the prevalence of obstructive CAD, in the
absence of calcium, was only 3.4 and 3.8 % in patients
with low and intermediate pretest CAD probability,
respectively. This is in line with the excellent prognosis
that has been demonstrated for patients with a calcium
score of zero [8].
In our population, older age (C55 years), hypertension
and dyslipidemia were independent predictors of CAD in
Table 3 Univariate analysis
No CAD
(n = 757)
CAD
(n = 107)
p
Demographic
Age C55 years 355 (47.0) 68 (63.6) 0.001
Male gender 335 (44.3) 54 (50.5) 0.254
Risk factors
Diabetes 64 (8.5) 14 (13.1) 0.147
Obesity (BMI C 30) 139 (18.4) 21 (19.6) 0.790
Hypertension 387 (51.1) 72 (67.3) 0.002
Dyslipidemia 385 (50.9) 69 (64.5) 0.010
Smoking 184 (24.3) 22 (20.6) 0.467
Family history of
premature CAD
248 (32.8) 36 (33.6) 0.913
Symptoms
Chest pain 371 (49.0) 52 (48.6) 1.000
CAD probability—Morise
Score C16 62 (8.2) 16 (15.0) 0.002
Score 9–15 382 (50.5) 64 (59.8)
Score 0–8 313 (41.3) 27 (25.2)
CAD probability—modified Diamond Forrester
Very low 171 (22.6 %) 17 (15.9) 0.005
Low 342 (45.2) 49 (45.8)
Intermediate 225 (29.8) 32 (29.9)
High 18 (2.4) 9 (8.4)
CV risk
Heart Score C5 79 (10.4) 24 (22.4) 0.001
Values are mean ± SD or n (%)
CAD coronary artery disease, BMI body mass index, CV
cardiovascular
Bold indicates p value with statistical significance
0.50 1.00 1.50 2.00 2.50
Hypertension 1.64
1
(1.051-
2.560)
Age   55 1.63
1
(1.054-
2.524)
Dyslipidemia 1.53
8
(1.002-
2.361)
OR (95% CI)
≥
Fig. 3 Independent predictors of CAD in patients with a CaSc of
zero
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this subset of patients without calcium, and in the presence
of these 3 predictors, the probability of having CAD was
almost 2 times higher than in the general population.
Nevertheless, the odds ratios for the independent predictors
were rather modest and other traditional CAD risk factors
were not found to be independent predictors. This way, we
could hypothesize that coronary plaques without calcium
could be a different phenotypical subset of CAD. Another
possibility could be that these patients with coronary pla-
ques in the absence of calcium represent CAD at earlier
stages, since calcium is considered to be associated with
more advanced forms of atherosclerotic lesions [2]. In fact,
in our population, all the patients with obstructive CAD
had only 1 vessel disease, most (93 %) with a single lesion,
and only a minority (36 %) had [70 % stenosis.
One last hypothesis could be that these plaques can have
microcalcifications below the threshold of cardiac CT
spacial resolution, as in the case example (Fig. 4), in which
small spots of calcium were only detected by intravascular
ultrasound (IVUS) virtual histology.
Limitations
There are a number of limitations related to this report: (1)
this is a single center retrospective study with medium size
cohort; (2) our population in mainly of low CAD proba-
bility and CV risk; the very low percentage of obstructive
CAD found can not be extrapolated to cohorts with more
patients with higher CAD probability and CV risk (3) the
definition of CAD was made using CCTA and not invasive
angiography, which may lead to false-positive findings,
although this is unlikely in the absence of calcium; (4) lack
of prognostic information, since we did not evaluate the
prognostic importance of obstructive CAD in patients with
a CaSc of zero.
Table 4 Prevalence of CAD according to the presence of risk factors found to be independent predictors
Independent preditors No CAD Nonobstructive CAD Obstructive CAD Total p
0 158 (96.9 %) 5 (3.1 %) 0 (0 %) 163 \0.001
1 210 (86.8 %) 25 (10.3 %) 7 (2.9 %) 242
2 250 (88.3 %) 28 (9.9 %) 5 (1.8 %) 283
3 139 (79.0 %) 35 (19.9 %) 2 (1.1 %) 176
757 93 14 864
Fig. 4 Non-calcified plaque on
cardiac CT (on the right) in a
patient with a CaSc of zero; the
angiography (on the left)
confirmed the presence of a
50–70 % stenosis in the mid-
RCA; intravascular ultrasound
with virtual histology (in the
middle) suggests the presence of
microcalcifications
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Conclusions
In this population of stable patients referred for evaluation
of possible CAD that had a calcium score of zero, 12.4 %
had coronary plaques and 1.6 % had obstructive (C50 %)
CAD.
Therefore, and despite the known high negative pre-
dictive value of CaSc for coronary events, the absence of
coronary artery calcification does not exclude the presence
of coronary artery disease, but the prevalence of obstruc-
tive disease is very low.
In this population, we found that age C55, hypertension,
dyslipidemia were independent predictors of CAD in the
setting of a calcium score of zero. In the presence of these 3
predictors, the probability of having CAD was almost 2
times higher than in the total studied population.
Conflict of interest All the authors declare that they have no con-
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